Healthcare · Pharmaceutical expenditure
Spain's pharmaceutical expenditure reaches 1.75 % GDP of GDP in 2026, ranking 34th out of 197 countries. This moderate level reflects strong state regulation of drug prices, widespread use of generics, and centralized procurement. At the same time, Spain is a major European pharmaceutical producer, with Catalonia hosting factories of global giants.
Data for 2026 · unit: % GDP
Position
#34 / 197
Spain world ranking
Country position on the scale from last to first place for this indicator.
ES
#34
#197#1
Trend
Change over time
Change in indicator over the available period.
1.10
1990
1.40
2000
1.70
2010
1.80
2020
1.75
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Spain stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Spain — how much?
Based on 2026 data — 1.75 % GDP. This is rank #34 out of 197 countries.
What is Spain's rank by Pharmaceutical expenditure?
Spain ranks #34 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Spain?
Over the available period the indicator changed from 1.10 to 1.75 % GDP.